Clinical Trial

Application of Device-based Training to Improve Postural Control in Older Adults With CCI

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to improve comprehensive rehabilitation programs for elderly patients with chronic cerebral ischemia by incorporating training methods with biofeedback for postural control training. The main objectives of the study are as follows: To evaluate the effectiveness of incorporating stabilometric training with biofeedback using the Huber system (LPG Systems, France) and treadmill-based biofeedback training using the C-Mill system (Physiomed Elektromedizin AG, Germany) into comprehensive rehabilitation programs, with respect to postural and cognitive functions in elderly patients with chronic cerebral ischemia. To conduct a comparative analysis of the effectiveness of training programs performed using the Huber (LPG Systems, France) and C-Mill (Physiomed Elektromedizin AG, Germany) biofeedback systems, based on outcomes related to gait pattern recovery, postural parameters, and cognitive performance. The investigators will compare training sessions using the Huber and C-Mill biofeedback systems with a control group (patients receiving conventional therapeutic exercise) in order to determine whether these devices are effective in improving postural control and reducing the risk of falls in patients with chronic cerebral ischemia. Participants are required to: Complete a course consisting of 8 procedures, performed once daily. Report any adverse events occurring during or after the procedures, should they arise.
Protocol Amendment History 1 change
notable Primary completion pushed: 2025-10-30 -> 2026-04-06 2026-05-06
Trial Details
NCT Number NCT07358338
Lead Sponsor Litvina Lyubov Dmitrievna
Conditions Cerebrovascular Disorders, Gait Disorders, Neurologic, Accidental Fall, Aged, Postural Balance
Enrollment 120 participants
Start Date 2025-06-01
Primary Completion 2026-04-06 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05